Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Enoxaparin sodium is a prescription low molecular weight heparin with anticoagulant activity. It is used to prevent deep vein thrombosis in selected surgical and acutely ill medical patients, treat acute deep vein thrombosis, reduce ischemic complications in unstable angina or non-Q-wave myocardial infarction, and treat acute ST-segment elevation myocardial infarction.
read more about enoxaparin ...Enoxaparin has antithrombotic activity that is measured largely through inhibition of factor Xa. Its low molecular weight heparin activity reduces formation and extension of fibrin-rich blood clots. The anticoagulant effect is stronger against factor Xa than against thrombin at standard treatment concentrations.
Enoxaparin is used for clot prevention after abdominal, hip, or knee surgery and in medical patients with severely restricted mobility during acute illness. It also treats acute deep vein thrombosis with or without pulmonary embolism and is used with aspirin for selected acute coronary syndromes and myocardial infarction.
Dosing depends on the indication, body weight, age, and kidney function. Hip or knee replacement prophylaxis commonly uses 30 mg subcutaneously every 12 hours. Acute deep vein thrombosis treatment commonly uses 1 mg per kg every 12 hours, while an inpatient regimen of 1.5 mg per kg once daily is another labeled option.
Enoxaparin carries a boxed warning for spinal or epidural hematomas in patients receiving neuraxial anesthesia or spinal puncture. Other serious concerns include major bleeding, heparin-induced thrombocytopenia with or without thrombosis, low platelet counts, and greater drug exposure in severe kidney impairment. Enoxaparin is not interchangeable unit for unit with other heparins.
Enoxaparin is a low molecular weight heparin anticoagulant with antithrombotic activity.
A common labeled regimen is 30 mg by subcutaneous injection every 12 hours after surgery.
A common regimen is 1 mg per kg subcutaneously every 12 hours.
Yes. The boxed warning concerns spinal or epidural hematomas associated with neuraxial procedures.
Enoxaparin. https://www.ncbi.nlm.nih.gov/books/NBK539865/. Date Accessed September 29, 2026.
Enoxaparin. https://pubmed.ncbi.nlm.nih.gov/30969687/. Date Accessed September 29, 2026.
Enoxaparin Injection: MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a601210.html. Date Accessed September 29, 2026.
Enoxaparin: A Review of Its Use in ST-Segment Elevation Myocardial Infarction. https://pubmed.ncbi.nlm.nih.gov/18370449/. Date Accessed September 29, 2026.
LOVENOX (Enoxaparin Sodium) Prescribing Information. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5017a927-2a24-4f27-89f9-27c805bf7d59. Date Accessed September 29, 2026.